520 likes | 548 Views
Infections of the Upper Respiratory Tract. Cynthia L. Gibert, M.D. Washington VA Medical Center. Upper Respiratory Infections. Upper respiratory tract infections are the most common human affliction. Major share of time lost from work and school. Most common cause of antibiotic abuse.
E N D
Infections of the Upper Respiratory Tract Cynthia L. Gibert, M.D. Washington VA Medical Center
Upper Respiratory Infections • Upper respiratory tract infections are the most common human affliction. • Major share of time lost from work and school. • Most common cause of antibiotic abuse.
Upper Respiratory Infections • Influenza • Epiglottitis • Sinusitis • The Common Cold
Influenza • Virus isolated in 1933 • A major cause of morbidity and mortality
Spanish Flu Pandemic of 1918 • Sept. - Nov. 1918 • 20-40 million deaths • More Americans died than in the WWI, WW2, Korea, Vietnam • 1st case Camp Fuston, Kansas - 3/4/18
Influenza A Pandemics 1918 - 1919 Spanish H1N1 1957 - 1958 Asian H2N2 1968 - 1969 Hong Kong H3N2
Influenza A 13 Hemagglutinin subtypes 9 Neuraminadase subtypes
Epidemiologic Characteristics • Pandemics Worldwide - antigenic shift • Epidemics Local - antigenic drift • Endemic Sporadic • Seasonal Winter months - abrupt • Age Infection: children > adults Mortality: adults > children
Pathogenesis • Virus replication: 24 - 72 hours • Virus excretion: 3 - 7 days • Antibodies to HA, NA subtypes
Secondary Bacterial Pathogens • S. pneumoniae • H. influenzae • S. aureus - Toxin Shock Syndrome
Reye’s Syndrome • Post influenza B • Encephalopathy • Hepatic dysfunction • Elevate NH3, LFTs, CPK
Influenza Vaccine Trivalent vaccine • A/Beijing/262/95-like (H1N1) • A/Sydney/5/97-like (H3N2) • B/Harbin/07/94
Indications for Vaccine • Elderly (age>65) • High-risk* • Household contacts • Health-care personnel • Pregnant women after 14th week High-risk: institutionalized, chronic heart or lung disease, diabetes, renal dysfunction, immunosuppressed, children on aspirin
Influenza Vaccine • Timing: October - Mid-November • Duration of immunity: start 1-2 weeks end 4-6 months
Diagnosis • Viral culture - tissue culture • Fluorescent-labeled murine monoclonal Ab - shell viral cell culture - viral Ag • PCR • CF - at onset and 2 weeks 4-fold-rise in Ab titre
Treatment of Influenza A Amantadine or rimantadine within 48 hours decreases fever and severity • Use in elderly or high risk • Hospitalized persons • Healthy adults
Prophylaxis of Influenza A • Control of outbreaks in institutions • Adjunct to late vaccination • Immunodeficient - AIDS • Vaccine contraindicated • Home caregivers of high risk
Epiglottitis - Acute Supraglottitis • A rapidly progressive and potentially fatal disease that must be recognized immediately.
Epiglottitis • Epidemiology: • most common in children 3-7 yrs. • decreased incidence because of Hib conjugate vaccine-stable rate in adults • Rate: • 1 in 1000-2000 pediatric admissions • 1 in 100,000 adult admissions
Differential Diagnosis of a Sore Throat • Peritonsillar abscess • sore throat, drooling, hoarseness, trismus, asymmetric tonsillar enlargement • Epiglottitis • Children: high fever, toxic, drooling, absence of cough • Adult: severe sore throat, dyshagia, fever • Infectious mononucleosis • tonsillar enlargement, exudative tonsillitis, pharyngeal inflammation, lymphadenopathy, splenomegaly, maculopapular rashes, petechial anathema • Parapharyngeal space infection • neck swelling after a sore throat
Epiglottitis - Pathogenesis • Haemophilus influenzae type b, S. pneumoniae, S. aureus, H. influenzae type non-b, H. parainfluenzae • Inflammation and edema of the epiglottis, arytenoids, arytenoepiglottic folds, subglottic area • Epiglottis pulled down into larynx and occludes the airway
Epiglottitis Clinical Manifestations • Abrupt onset - sore throat, fever, toxicity dysphagia, drooling, stridor, chest wall retractions • Beefy-red epiglottis • Inspiratory stridor and expiratory ronchi • Adults: muffled voice, drooling
Epiglottitis - Diagnosis • Visualization of epiglottis - “cherry red” • Laternal neck x-rays: “thumb sign” • WBC count > 15,000 left shift • Blood cultures
Differential Diagnosis • Viral croup - barking cough, less abrupt, less toxic • Bacterial tracheitis - S. aureus, H. influenzae, Strept., diphtheria • Aspiration of a foreign body
Therapy • Adequate airway - nasotracheal intubation • Adults - close observation • Antibiotics • cefuroxime, ceftriaxone • ampicillin resistance - up to 30% • chloramphenicol ? Corticosteroids - reduce postintubation inflammation
Prevention Rifampin - 20 mg/kg for 4 days • All household contacts if children under 4 • Daycare and nursery school contacts • Patient before discharge
Sinusitis - Clinical Findings • Viral URI, fever (50%), purulent nasal discharge, swelling, facial pain worse on percussion, headache, nasal obstruction, loss of smell • Children: facial pain, swelling, malodorous breath (50%), cough (80%), nasal discharge (76%), fever (63%), sore throat (23%)
Specific Clinical Criteria • Maxillary toothache, colored nasal discharge, poor response to nasal decongestants, abnormal transillumination, purulent secretions, cough > 7 days
Diagnosis • Nasal swabs not helpful • Transillumination of maxillary and frontal sinuses • Sinus x-rays: air-fluid level, complete opacity, mucosal thickening • CT scan not indicated - unless chronic infection, immunocompromised, suspected intracranial or orbital complication • Direct sinus aspiration
Factors that Predispose to Sinusitis • Impaired mucociliary function • Obstruction of sinus ostia • Immune defects • Increased risk of microbial invasion
Microbial Causes of Acute Maxillary Sinusitis PREVALENCE MEAN (RANGE) Adults Children MICROBIAL AGENT (Bacteria) (%) (%) Streptococcus pneumoniae 31 (20-35) 36 Haemophilus influenzae 21 (6-26) 23 (nonencapsulated) S. pneumoniae and H. influenzae 5 (1-9) -- Anaerobes (Bacteroides, Fusobacterium, 6 (0-10) -- Peptostreptococcus, Veillonella) Staphylococcus aureus 4 (0-8) -- Streptococcus pyogenes 2 (1-3) 2 Branhamella (Moraxella) catarrhalis 2 19 Gram-negative bacteria 9 (0-24) 2
Microbial Causes of Acute Maxillary Sinusitis PREVALENCE MEAN (RANGE) Adults Children MICROBIAL AGENT (%) (%) Viruses Rhinovirus 15 -- Influenza virus 5 -- Parainfluenza virus 3 2 Adenovirus -- 2
Decongestants • Oxymetazoline HCL - TID for 48-72 hours • Pseudoephedrine HCL - only if allergic component • Nasal steroids for 2-3 weeks
Therapy Empiric antibiotics for 10 days • Amoxicillin/ampicillin • TMP/SMX • Cephalosporin - cefaclor, cefuroxime • Azithromycin, clarithromycin
Chronic Sinusitis • Symptoms for > 3 months Allergies, inadequately treated • Aerobes and anaerobes • ENT evaluation for endoscopy or CT • Antibiotics for 3-4 weeks
Caveat • Frontal sinusitis with tenderness and headache - thin barrier to CNS • Treat 10-14 days
Ethmoid and Sphenoid Sinusitis • Ethmoid sinusitis: edema of eyelids, tearing, retroorbital pain, proptosis • Sphenoid sinusitis: intractable headache, hypo/hyperesthesia of ophthalmic or maxillary branches of trigeminal n. (30%)
Cavernous Sinus Thrombosis • Depressed mental status • Meningeal irritation • Ptosis, chemosis • Proptopsis • C.N. palsies - III, IV, VI
Intracranial Complications of Sinusitis ComplicationClinical Signs • Meningitis Headache, fever, stiff neck lethargy, rapid death • Osteomyelitis Pott’s puffy tumor • Epidural abscess Headache, fever • Subdural empyema Headache, seizures hemiplegia, rapid death • Cerebral abscess Convulsions, headache, personality change • Venous sinus thrombosis Picket-fence fever, rapid death • Cavernous sinus Orbital edema, ocular palsies
The Common Cold • Hippocrates: • rejected bleeding • Pliny the Younger: • kiss the hairy muzzle of a mouse • Ben Franklin: • not from exposure to cold/dampness; • close contact
Epidemiology • 65 million colds per year • 150 million days of restricted activity • 24 million medical visits • 18 million days lost from work • 22 million days missed from school
VirologyOver 200 viruses Virus type Serotypes Andenoviruses 41 Coronaviruses 2 Influenza viruses 3 Parainfluenza viruses 4 Respiratory syncytial virus 1 Rhinoviruses 100+ Enteroviruses 60+
Seasonal Variation • May-Aug - Enteroviruses • Sept-Dec - Mycoplasma, Rhinoviruses, Parainf. 1+2, RSV • Jan-Feb - Adenoviruses, Influenza, Coronaviruses • Mar-Apr - Parainf. 3, Rhinoviruses
Transmission • Direct contact with infected secretions • Hand - to - hand • Hand - to environmental surface - to hand • Spread by aerosoles
Pathogenesis • Incubation period 1 - 4 days • Begins in posterior pharynx • Viral shedding days 3 - 4
Clinical Presentation Dry, scratchy, sore throat Sneezing, nasal stuffiness, rhinorrhea Malaise, myalgia, headache Hoarseness, cough, low grade fever
Complications • Bacterial superinfection • Otitis media • Sinusitis • S. pneumoniae, H. influenzae, B. catarrhalis • Guillain-Barre Syndrome • Asthma attacks
Management • Throat culture, rapid Ag detection for group A strep • Diagnosis of influenza A, RSV
Use of Antibiotics • No benefit • Do not reduce bacterial complications • Emergence of resistant organisms